What is the share price of Medi-Caps Ltd (MEDICAPQ) today?
The share price of MEDICAPQ as on 11th July 2025 is ₹43.06. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Medi-Caps Ltd (MEDICAPQ) share?
The past returns of Medi-Caps Ltd (MEDICAPQ) share are- Past 1 week: 4.05%
- Past 1 month: 0.72%
- Past 3 months: -0.36%
- Past 6 months: -18.44%
- Past 1 year: -14.03%
- Past 3 years: -9.80%
- Past 5 years: 300.55%
What are the peers or stocks similar to Medi-Caps Ltd (MEDICAPQ)?
The peers or stocks similar to Medi-Caps Ltd (MEDICAPQ) include:What is the market cap of Medi-Caps Ltd (MEDICAPQ) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medi-Caps Ltd (MEDICAPQ) is ₹54.49 Cr as of 11th July 2025.What is the 52 week high and low of Medi-Caps Ltd (MEDICAPQ) share?
The 52-week high of Medi-Caps Ltd (MEDICAPQ) is ₹61 and the 52-week low is ₹37.23.What is the PE and PB ratio of Medi-Caps Ltd (MEDICAPQ) stock?
The P/E (price-to-earnings) ratio of Medi-Caps Ltd (MEDICAPQ) is -97.31. The P/B (price-to-book) ratio is 0.45.Which sector does Medi-Caps Ltd (MEDICAPQ) belong to?
Medi-Caps Ltd (MEDICAPQ) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Medi-Caps Ltd (MEDICAPQ) shares?
You can directly buy Medi-Caps Ltd (MEDICAPQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Medi-Caps Ltd
MEDICAPQ Share Price
43.061.46% (-0.64)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDICAPQ Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MEDICAPQ Performance & Key Metrics
MEDICAPQ Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -95.60 | 0.45 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.59 | 6.40 | 0.79% |
MEDICAPQ Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
MEDICAPQ Company Profile
Medi-Caps is a pharmaceutical company manufacturing allopathic pharmaceutical preparations
SUNPHARMA
PE Ratio
36.50
36.50
1Y Return
4.00%
4.00%
Buy Reco %
87.10
87.10
CIPLA
PE Ratio
22.64
22.64
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.13
59.13
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.58
18.58
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
MANKIND
PE Ratio
52.73
52.73
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
MEDICAPQ Forecast
MEDICAPQ Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
MEDICAPQ
MEDICAPQ
Income
Balance Sheet
Cash Flow
Annual Normal View
MEDICAPQ Income Statement
MEDICAPQ Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 46.07 | 54.77 | 54.52 | 45.92 | 59.30 | 71.82 | 50.97 | 27.83 | 28.21 | 28.20 | ||||||||||
Raw Materials | 20.25 | 22.77 | 24.55 | 21.92 | 27.78 | 27.56 | 20.35 | 7.67 | 27.30 | 27.30 | ||||||||||
| Power & Fuel Cost | 4.74 | 5.29 | 5.14 | 3.86 | 2.64 | 3.35 | 2.25 | 1.55 | ||||||||||||
| Employee Cost | 8.11 | 8.27 | 8.96 | 10.70 | 4.95 | 5.62 | 5.65 | 5.21 | ||||||||||||
| Selling & Administrative Expenses | 6.02 | 10.01 | 5.17 | 5.06 | 6.77 | 18.13 | 11.63 | 9.19 | ||||||||||||
| Operating & Other expenses | 3.32 | 5.19 | 3.25 | 8.29 | 4.42 | 5.14 | 4.41 | 3.72 | ||||||||||||
EBITDA | 3.63 | 3.24 | 7.45 | -3.91 | 12.74 | 12.02 | 6.68 | 0.49 | 0.91 | 0.90 | ||||||||||
| Depreciation/Amortization | 1.81 | 1.79 | 1.82 | 1.83 | 1.52 | 1.81 | 1.74 | 1.69 | 1.72 | 1.72 | ||||||||||
| PBIT | 1.82 | 1.45 | 5.63 | -5.74 | 11.22 | 10.21 | 4.94 | -1.20 | -0.81 | -0.82 | ||||||||||
| Interest & Other Items | 0.10 | 0.10 | 0.13 | 0.12 | 0.10 | 0.11 | 0.13 | 0.04 | 0.02 | 0.02 | ||||||||||
| PBT | 1.72 | 1.35 | 5.50 | -5.86 | 11.12 | 10.10 | 4.81 | -1.24 | -0.83 | -0.84 | ||||||||||
| Taxes & Other Items | 0.35 | 0.20 | 0.12 | 0.01 | -0.01 | 0.01 | 3.06 | 1.00 | -0.27 | -0.27 | ||||||||||
| Net Income | 1.37 | 1.15 | 5.38 | -5.87 | 11.13 | 10.09 | 1.75 | -2.24 | -0.56 | -0.57 | ||||||||||
| EPS | 1.10 | 0.92 | 4.31 | -4.71 | 8.93 | 8.09 | 1.40 | -1.80 | -0.46 | -0.46 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MEDICAPQ Company Updates
MEDICAPQ Stock Peers
MEDICAPQ Past Performance & Peer Comparison
MEDICAPQ Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Medi-Caps Ltd | -97.31 | 0.45 | — |
| Sun Pharmaceutical Industries Ltd | 36.50 | 5.50 | 0.96% |
| Cipla Ltd | 22.64 | 3.82 | 1.08% |
| Torrent Pharmaceuticals Ltd | 59.13 | 14.89 | 0.18% |
MEDICAPQ Stock Price Comparison
Compare MEDICAPQ with any stock or ETFCompare MEDICAPQ with any stock or ETF
MEDICAPQ
MEDICAPQ Holdings
MEDICAPQ Shareholdings
MEDICAPQ Promoter Holdings Trend
MEDICAPQ Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MEDICAPQ Institutional Holdings Trend
MEDICAPQ Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MEDICAPQ Shareholding Pattern
MEDICAPQ Shareholding Pattern
MEDICAPQ Shareholding History
MEDICAPQ Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MEDICAPQ stock
smallcases containing MEDICAPQ stock
Looks like this stock is not in any smallcase yet.
MEDICAPQ Events
MEDICAPQ Events
MEDICAPQ Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDICAPQ has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDICAPQ Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDICAPQ has not given any dividends in last 5 years
MEDICAPQ Upcoming Dividends
MEDICAPQ Upcoming Dividends
No upcoming dividends are available
MEDICAPQ Past Dividends
MEDICAPQ Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2012
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 20, 2012
Cash Dividend
Ex DateEx DateSep 22, 2011
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 22, 2011
MEDICAPQ Stock News & Opinions
MEDICAPQ Stock News & Opinions
Articles & Videos
Earnings
Medi Caps reports consolidated net profit of Rs 1.72 crore in the March 2025 quarter
Net profit of Medi Caps reported to Rs 1.72 crore in the quarter ended March 2025 as against net loss of Rs 1.08 crore during the previous quarter ended March 2024. Sales declined 6.47% to Rs 6.94 crore in the quarter ended March 2025 as against Rs 7.42 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.57 crore in the year ended March 2025 as against net loss of Rs 2.24 crore during the previous year ended March 2024. Sales declined 4.48% to Rs 25.37 crore in the year ended March 2025 as against Rs 26.56 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales6.947.42 -6 25.3726.56 -4 OPM %-3.31-6.74 --7.21-0.15 - PBDT1.89-0.26 LP 0.880.44 100 PBT1.45-0.59 LP -0.84-1.25 33 NP1.72-1.08 LP -0.57-2.24 75 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Medi Caps to announce Quarterly Result
Medi Caps will hold a meeting of the Board of Directors of the Company on 21 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Medi Caps reports consolidated net loss of Rs 2.05 crore in the December 2024 quarter
Net Loss of Medi Caps reported to Rs 2.05 crore in the quarter ended December 2024 as against net loss of Rs 0.16 crore during the previous quarter ended December 2023. Sales declined 42.05% to Rs 4.01 crore in the quarter ended December 2024 as against Rs 6.92 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales4.016.92 -42 OPM %-44.3910.12 - PBDT-1.620.79 PL PBT-2.050.34 PL NP-2.05-0.16 -1181 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Medi Caps to convene board meeting
Medi Caps will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Medi Caps consolidated net profit rises 158.33% in the September 2024 quarter
Net profit of Medi Caps rose 158.33% to Rs 0.31 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ended September 2023. Sales rose 38.23% to Rs 8.28 crore in the quarter ended September 2024 as against Rs 5.99 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales8.285.99 38 OPM %5.438.35 - PBDT0.740.57 30 PBT0.310.12 158 NP0.310.12 158 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Medi Caps to discuss results
Medi Caps will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Medi Caps to hold AGM
Medi Caps announced that the 41th Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Medi Caps reports consolidated net loss of Rs 0.56 crore in the June 2024 quarter
Net Loss of Medi Caps reported to Rs 0.56 crore in the quarter ended June 2024 as against net loss of Rs 1.11 crore during the previous quarter ended June 2023. Sales declined 1.44% to Rs 6.15 crore in the quarter ended June 2024 as against Rs 6.24 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales6.156.24 -1 OPM %-4.55-11.70 - PBDT-0.13-0.66 80 PBT-0.56-1.11 50 NP-0.56-1.11 50 Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Medi Caps to declare Quarterly Result
Medi Caps will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Medi-Caps Standalone December 2023 Net Sales at Rs 3.05 crore, up 23895.28% Y-o-Y
1 year agoMoneycontrol
Over the last 5 years, revenue has grown at a yearly rate of -9.28%, vs industry avg of 10.1%
Over the last 5 years, market share decreased from 0.02% to 0.01%